When we asked whether their overexpression is also correlated with patients’ poor survival in other cancer types from the TCGA Pan-Cancer dataset, we observed that high NSMCE2 RNA expression levels associate with worse overall survival in 6 other cancer types: pancreatic ductal adenocarcinoma, uveal melanoma, kidney papillary cell carcinoma, lung adenocarcinoma, sarcoma and brain lower grade glioma (Table S2). This evidence concerns the gene NSMCE2 and sarcoma.